Murphy Canyon Acquisition Corp.
MURFU
NASDAQ Global Market16.56
USD
-2.54
- -
CIK
0001896212
Return %
Stock
S&P500
1Y
62.19
26.53
3Y
65.10
76.60
5Y
65.10
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jack Kendrick Heilbron
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 4995 Murphy Canyon Road San Diego CA United States of America 92123
- IPO Date
- Feb 3, 2022
- CIK
- 0001896212
- Website
- murphycanyonac.com
- Similar Companies
- Business
- Murphy Canyon Acquisition Corp. (NASDAQ:MURFU) is a blank check company sponsored by Presidio Property Trust, Inc. that conducts no significant operations and exists primarily to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar initial business combination with one or more businesses. The company focuses its acquisition efforts on the real estate sector, including construction and homebuilding; real estate owners and operators; arrangers of real estate financing; insurance and related services for real estate; and adjacent proptech businesses and technologies with enterprise values between $300 million and $1.2 billion. Founded in 2021 and headquartered in San Diego, California, it generates no products or revenue prior to completing an initial business combination and maintains proceeds from its February 2022 initial public offering of 13.225 million units at $10 each, totaling $132.25 million including the underwriters' over-allotment option, in a trust account for use in a target acquisition. In September 2023, the company announced and received stockholder approval for a proposed business combination with Conduit Pharmaceuticals Limited, a clinical-stage life science firm developing pharmaceutical compounds, with the deal including a concurrent $20 million private placement by an institutional investor; although the transaction was positioned to result in a name change to Conduit Pharmaceuticals Inc. and new tickers CDT and CDTTW, Murphy Canyon Acquisition Corp. continues to trade actively as of late 2025 under MURF and MURFU with a market capitalization around $21-28 million, recent quarterly net losses of approximately $5 million, and no confirmed completion or liquidation as its website and filings affirm an ongoing search for a real estate-focused target without substantive discussions formalized.
U.S. IPO Weekly Recap: The February IPO Market Kicks Off With 2 Biotechs